Innate Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	117	160	211	264	352	273
Market Cap Growth	-30.80%	-24.29%	-19.93%	-24.98%	28.64%	-41.60%
Enterprise Value	84	104	163	184	249	144
Last Close Price	1.25	1.93	2.62	3.29	4.45	3.46
Forward PE	-	4.33	-	-	-	-
PS Ratio	9.27	7.95	3.43	4.58	14.24	3.92
PB Ratio	22.78	18.11	4.07	4.87	3.27	1.75
P/TBV Ratio	22.78	18.11	4.10	5.02	5.56	2.49
EV/Sales Ratio	6.66	5.15	2.65	3.19	10.07	2.07
EV/EBITDA Ratio	-	-	-	-	-	10.86
EV/EBIT Ratio	-	-	-	-	-	133.87
EV/FCF Ratio	-2.04	-	-	-	-	-
Debt / Equity Ratio	5.25	3.51	0.77	0.78	0.41	0.12
Debt / EBITDA Ratio	-	-	-	-	-	1.33
Net Debt / Equity Ratio	-6.41	-5.63	-1.01	-1.09	-0.70	-0.85
Net Debt / EBITDA Ratio	0.66	0.99	6.16	4.93	1.75	-9.96
Net Debt / FCF Ratio	0.80	6.83	1.60	3.01	1.27	2.52
Asset Turnover	0.10	0.14	0.33	0.25	0.09	0.20
Quick Ratio	2.08	2.50	3.51	3.21	1.67	3.64
Current Ratio	2.21	2.60	3.73	3.38	1.73	3.81
Return on Equity (ROE)	-271.37%	-162.91%	-14.28%	-71.75%	-34.53%	-0.44%
Return on Assets (ROA)	-25.92%	-22.52%	-4.23%	-4.40%	-10.40%	0.19%
Return on Invested Capital (ROIC)	-	-	-	-122.70%	-173.03%	5.30%
Return on Capital Employed (ROCE)	-79.80%	-66.10%	-9.30%	-10.40%	-25.50%	0.40%
Earnings Yield	-39.31%	-30.93%	-3.58%	-22.02%	-15.02%	-23.41%
FCF Yield	-35.22%	-4.56%	-15.58%	-7.46%	-16.89%	-19.27%
Buyback Yield / Dilution	-4.15%	-0.74%	-1.02%	-0.12%	-0.77%	-17.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.